News

September 29, 2020
|
Category:

Dewpoint Therapeutics Series B $77M raise gains significant media attention

The announcement of Dewpoint Therapeutics successful $77 million Series B raise has received significant attention in from both Industry and main-stream media. A selection of key coverage and analysis can be found via the links below.

Read more on bostonglobe.com

Read more on endpts.com

Read more on fiercebiotech.com

Media Contact

media@dewpointx.com

Investor Contact

Michael Fenn, PH.D.
Head of External Innovation
Dewpoint Therapeutics
mfenn@dewpointx.com
Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
USA
© 2019-2024 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science